[1] |
LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao.
Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
|
[2] |
SUN Yuanyuan, DENG Kunhong, WANG Siyi, KUANG Yun, ZOU Chan, GUO Chengxian, HE Qingnan, LIU Helin, YANG Guoping.
Design and implementation of electronic identity application for gene-directed personalized medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 274-280.
|
[3] |
XING Kai, GONG Jinyu, LUO Jianquan.
Advances on pharmacogenomics of diuretics-related adverse reactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212.
|
[4] |
.
Research Progress of Pharmacogenomics of Dabigatran Etexilate and Rivaroxaban
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1200-1207.
|
[5] |
XIE Shangchen, LI Wei, LIAO Ping, HE Yijing, MCLEOD Howard L..
Research progress of general anesthesia in the pharmacogenetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 217-222.
|
[6] |
ZHAO De-heng, XIAO Hui-lai.
FDA's recommentdations on pharmacogenomics studies in early-phase clinical studies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 208-212.
|
[7] |
ZHANG Yue-li, MING Ying-zi, ZHOU Hong-hao, ZHANG Wei.
Tacrolimus pathways:pharmacokinetics,pharmacodynamics and pharmacogenomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1042-1049.
|
[8] |
LIN Mei-qin, ZHANG Jing, YU Liang-ping, SONG Hong-tao.
Advances of individualized administration model of warfarin based on pharmacogenomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1299-1305.
|
[9] |
TAO Ran, HUANG Hong-guang, GAO Li-chen.
Advances in pharmacogenomics research of adverse effects of hypertension therapy drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1183-1188.
|
[10] |
HUANG Zheng-yu, LIU Fang-qun, GAO Li-chen, WANG Di, HE Yi-jing, CHENG Xiao-ping.
Advances in pharmacogenomics of cyclophosphamide in the breast cancer therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1196-1200.
|
[11] |
HU Lei, GAO Li-chen, ZHUO Wei, ZHOU Hong-hao, FAN Lan.
Advances in pharmacogenomics of cytochrome P450 oxidoreductase
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(7): 821-827.
|
[12] |
LUO Jian-quan, ZHANG Wei.
Research progress on human leucocyte antigen gene polymorphisms and drug adverse reactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(7): 828-834.
|
[13] |
LUO Zhi-ying, ZHANG Wei.
The educational strategies for pharmacogenomics Translational Medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(5): 588-592.
|
[14] |
GAO Li-chen, ZHANG Wei, LIU Zhao-qian, FAN Lan, ZHOU Hong-hao.
Progress in clinical herb-drug interactions mediated by drug metabolism- related genes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 346-351.
|
[15] |
SHEN Jie, XIE Hai-tang, LIU Zhao-qian.
Adrancement in pharmacogentics and hypenteasion medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 705-714.
|